Anas Abdo

Prof. Dr. Anas Abdo


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in Heliyon
Verified
Journal Article
Open access
AAAmirah Alnour
Amirah Alnour
GAGhassan Almohammad
Ghassan Almohammad
AAAnas Abdo
Anas Abdo
KLKinda Layous
Kinda Layous
Recently, vital pulp therapy is widely used all over the world. It aims to maintain the viability and function of the injured dental pulp tissue. Direct pulp capping is recognized as one of the most common used techniques in this approach. we aimed to compare the histopathological response of the dental pulp following direct pulp capping using two different capping materials; the exogenous nitric oxide (NOC-18) and Mineral Trioxide Aggregate (MTA) in dogs’ teeth. The pulp of thirty-two premolars and canines from four dogs (eight teeth per each dog) the pulp was exposed and treated with either exogenous nitric oxide (NOC-18) and MTA (four teeth in each group). The treated teeth were extracted and prepared for histologic evaluation after one month and three months, respectively. The histologic study evaluated the formation of dentine bridge, the degree of pulpitis, calcification of the coronal pulp tissue and odontoblasts layer activity. We have the ethical approval to achieve this research from the scientific committee in Faculty of Dentistry, Damascus University. The results showed that the active statue of odontoblasts layer in NOC-18 group was significantly more than in MTA group after a month of recall (P: 0.003). No significant difference was found between MTA and NOC-18 categories in the formation of dentine bridge after 3 months (P: 1.000). Exogenous nitric oxide (NOC-18) maybe has a positive impact on formation of calcified bridge and efficacy of odontoblasts layer on directly capped dog's teeth. Exogenous NO donors might offer alternative to current pulp capping agents in Vital Pulp Therapy in endodontic.

8 November 2022 in Cureus
Verified
Journal Article
Open access
AAAnas A Alyahya
Anas A Alyahya
MRMohamad Salem Rekab
Mohamad Salem Rekab
AAAlaa Eddin O Al-Ostwani
Alaa Eddin O Al-Ostwani
AAAnas Abdo
Anas Abdo
KKKamal Kayed
Kamal Kayed
The use of a chelating agent as an adjunct to disinfectant irrigation is very necessary to remove the smear layer formed during root canal treatment. However, the decalcifying solutions have a negative impact on dentin microhardness, which might affect the result of endodontic therapy. The aim of this study is to evaluate the effect of 17% ethylenediamine tetraacetic acid (EDTA), a novel silver-citrate root canal irrigation solution (BioAkt), 10% citric acid, and 40% citric acid on the microhardness of root canal dentin. Forty-five single-root teeth were distributed equally into five groups A, B, C, D, and E treated with distilled water as a control, 17% EDTA, BioAkt, 10% citric acid, and 40% citric acid, respectively. The dentin microhardness was measured before and after the experiment, and the collected data were analyzed using paired sample T-test, One-way ANOVA test, and least significant difference (LSD) test (multiple comparisons), (P < 0.05). The results showed that the averages of dentin microhardness values before the experiment were 62.83 kg/mm², 65.34 kg/mm², 64.79 kg/mm², 62.95 kg/mm², and 56.47 kg/mm² for groups A, B, C, D, and E, respectively, while the averages after the experiment were 62.60 kg/mm², 54.92 kg/mm², 54.50 kg/mm², 51.31 kg/mm², and 49.37kg/mm² accordingly. Statistical analysis revealed that 17% EDTA, BioAkt, 10% citric acid, and 40% citric acid decreased the dentin microhardness significantly comparing with the negative control group, without statistical differences among them. The chelating agents 17% EDTA, BioAkt, 10% citric acid, and 40% citric acid declined the microhardness of root canal dentin similarly, which might have possible effects on endodontic treatment and the properties of root canal filling materials as well.

11 August 2026 in Lasers in Medical Science
Verified
Journal Article
Open access
PDF file
MSM. Talal Sadeldin
M. Talal Sadeldin
OHOmar Hamadah
Omar Hamadah
AAAnas Abdo
Anas Abdo
LSLana Sayal
Lana Sayal
AAAmirah Alnour
Amirah Alnour
Skeletal muscle tissue has considerable regenerative capacity following injury; yet, this process may be gradual and constrained. Bupivacaine, a local anaesthetic, serves as a model for inducing muscle damage in experimental research. Low-level laser treatment (LLLT), also referred to as photobiomodulation (PBM) has demonstrated considerable efficacy in promoting the healing of skeletal muscle tissue. The aim of this study was to evaluate the effect of LLLT (810 nm) on skeletal muscle regeneration following bupivacaine-induced myonecrosis in a rabbit model. This study was structured as a controlled experimental trial with 16 test subjects, uniformly allocated into groups. Bupivacaine hydrochloride 0.5% was administered locally to produce skeletal muscle damage. The experimental groups subsequently had low-level laser therapy (LLLT) at a wavelength of 810 nanometers, according to standardized protocols. Gastrocnemius muscle samples were collected for histological examination and hematoxylin-eosin staining to evaluate the stages of healing and to measure the extent of degeneration in skeletal muscle tissue by analysing creatine kinase (CK) protein levels. Bupivacaine injection resulted in significant muscle fiber degeneration, inflammation, and elevated serum CK levels. Compared to the bupivacaine-only groups, LLLT-treated animals showed significantly lower dystrophy scores (p=0.039), reduced inflammatory infiltration at day 6 (p=0.011), and substantially lower CK levels at both 3 days (1560 ± 722 vs 4500 ± 1733 IU/L) and 6 days (1090 ± 383 vs 3043 ± 1047 IU/L) (p<0.05). Centrally located myonuclei, a marker of active regeneration, were observed only in the LLLT group at the 6-day time point (approximately 28% of fibers). The current findings suggest that LLLT at 810 nm may accelerate histological recovery and attenuate muscle damage markers following bupivacaine-induced myonecrosis in rabbits. Further large-scale studies incorporating molecular and immunohistochemical analyses are warranted to confirm these results and elucidate the underlying mechanisms.